Orthopediatrics (KIDS) Preferred Stock Liabilities (2016 - 2017)

Orthopediatrics' (KIDS) quarterly Preferred Stock Liabilities came in at $75.7 million in Q3 2017, up 6.12% on a QoQ basis from $71.3 million in Q4 2016.

Orthopediatrics (KIDS) Preferred Stock Liabilities (2016 - 2017) Analysis & Trends

Orthopediatrics (KIDS) has 2 years of Preferred Stock Liabilities data on file, last reported at $75.7 million in Q3 2017.

  • On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $75.7 million in Q3 2017; TTM through Sep 2017 was $75.7 million, a N/A change from a year earlier, with the FY2016 full-year figure at $71.3 million, up 62.89% from the prior year.
  • Preferred Stock Liabilities for Q3 2017 stood at $75.7 million, up from $71.3 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for KIDS reached as high as $75.7 million in Q3 2017 and fell as low as $71.3 million in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Orthopediatrics 443.38 Mn 429.14 Mn 43.39 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2017 75.67 Mn
Dec 31, 2016 71.30 Mn